Tenaya Therapeutics, Inc. (TNYA) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$93.33M | +19.5% |
| 2024 | -$115.95M | +11.6% |
| 2023 | -$131.19M | -4.4% |
| 2022 | -$125.62M | -72.5% |
| 2021 | -$72.81M | -87.1% |
| 2020 | -$38.91M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$93.33M | +19.5% |
| 2024 | -$115.95M | +11.6% |
| 2023 | -$131.19M | -4.4% |
| 2022 | -$125.62M | -72.5% |
| 2021 | -$72.81M | -87.1% |
| 2020 | -$38.91M | — |